Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 2
1962 1
1964 9
1965 4
1966 2
1967 3
1969 6
1970 5
1971 6
1972 7
1973 4
1974 9
1975 4
1976 6
1977 10
1978 9
1979 7
1980 7
1981 9
1982 5
1983 15
1984 8
1985 11
1986 11
1987 26
1988 16
1989 19
1990 24
1991 25
1992 17
1993 18
1994 22
1995 17
1996 21
1997 24
1998 41
1999 28
2000 45
2001 29
2002 37
2003 44
2004 37
2005 36
2006 58
2007 44
2008 68
2009 63
2010 77
2011 80
2012 83
2013 87
2014 96
2015 104
2016 117
2017 119
2018 88
2019 124
2020 119
2021 115
2022 37
Text availability
Article attribute
Article type
Publication date

Search Results

1,945 results
Results by year
Filters applied: . Clear all
Page 1
In Vitro and Animal Models for SARS-CoV-2 research.
Takayama K. Takayama K. Trends Pharmacol Sci. 2020 Aug;41(8):513-517. doi: 10.1016/j.tips.2020.05.005. Epub 2020 May 30. Trends Pharmacol Sci. 2020. PMID: 32553545 Free PMC article. Review.
Autoimmunity roots of the thrombotic events after COVID-19 vaccination.
Elrashdy F, Tambuwala MM, Hassan SS, Adadi P, Seyran M, Abd El-Aziz TM, Rezaei N, Lal A, Aljabali AAA, Kandimalla R, Bazan NG, Azad GK, Sherchan SP, Choudhury PP, Serrano-Aroca Á, Takayama K, Chauhan G, Pizzol D, Barh D, Panda PK, Mishra YK, Palù G, Lundstrom K, Redwan EM, Uversky VN. Elrashdy F, et al. Among authors: takayama k. Autoimmun Rev. 2021 Nov;20(11):102941. doi: 10.1016/j.autrev.2021.102941. Epub 2021 Sep 9. Autoimmun Rev. 2021. PMID: 34508917 Free PMC article. Review.
COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street?
Lundstrom K, Barh D, Uhal BD, Takayama K, Aljabali AAA, Abd El-Aziz TM, Lal A, Redwan EM, Adadi P, Chauhan G, Sherchan SP, Azad GK, Rezaei N, Serrano-Aroca Á, Bazan NG, Hassan SS, Panda PK, Pal Choudhury P, Pizzol D, Kandimalla R, Baetas-da-Cruz W, Mishra YK, Palu G, Brufsky AM, Tambuwala MM, Uversky VN. Lundstrom K, et al. Among authors: takayama k. Biomolecules. 2021 Jul 13;11(7):1020. doi: 10.3390/biom11071020. Biomolecules. 2021. PMID: 34356644 Free PMC article. Review.
Corrigenda.
Matsumoto T, Takayama K, Ishida K, Hayashi S, Hashimoto S, Kuroda R. Matsumoto T, et al. Among authors: takayama k. Bone Joint J. 2021 Oct;103-B(10):1641. doi: 10.1302/0301-620X.103B10.BJJ-2021-00021. Bone Joint J. 2021. PMID: 34587812 No abstract available.
Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
Katakami N, Uchino J, Yokoyama T, Naito T, Kondo M, Yamada K, Kitajima H, Yoshimori K, Sato K, Saito H, Aoe K, Tsuji T, Takiguchi Y, Takayama K, Komura N, Takiguchi T, Eguchi K. Katakami N, et al. Among authors: takayama k. Cancer. 2018 Feb 1;124(3):606-616. doi: 10.1002/cncr.31128. Epub 2017 Dec 4. Cancer. 2018. PMID: 29205286 Free PMC article. Clinical Trial.
A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia.
Hamauchi S, Furuse J, Takano T, Munemoto Y, Furuya K, Baba H, Takeuchi M, Choda Y, Higashiguchi T, Naito T, Muro K, Takayama K, Oyama S, Takiguchi T, Komura N, Tamura K. Hamauchi S, et al. Among authors: takayama k. Cancer. 2019 Dec 1;125(23):4294-4302. doi: 10.1002/cncr.32406. Epub 2019 Aug 15. Cancer. 2019. PMID: 31415709 Free PMC article.
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.
Taniguchi H, Yamada T, Wang R, Tanimura K, Adachi Y, Nishiyama A, Tanimoto A, Takeuchi S, Araujo LH, Boroni M, Yoshimura A, Shiotsu S, Matsumoto I, Watanabe S, Kikuchi T, Miura S, Tanaka H, Kitazaki T, Yamaguchi H, Mukae H, Uchino J, Uehara H, Takayama K, Yano S. Taniguchi H, et al. Among authors: takayama k. Nat Commun. 2019 Jan 16;10(1):259. doi: 10.1038/s41467-018-08074-0. Nat Commun. 2019. PMID: 30651547 Free PMC article.
Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer.
Wang R, Yamada T, Kita K, Taniguchi H, Arai S, Fukuda K, Terashima M, Ishimura A, Nishiyama A, Tanimoto A, Takeuchi S, Ohtsubo K, Yamashita K, Yamano T, Yoshimura A, Takayama K, Kaira K, Taniguchi Y, Atagi S, Uehara H, Hanayama R, Matsumoto I, Han X, Matsumoto K, Wang W, Suzuki T, Yano S. Wang R, et al. Among authors: takayama k. Nat Commun. 2020 Sep 14;11(1):4607. doi: 10.1038/s41467-020-18442-4. Nat Commun. 2020. PMID: 32929081 Free PMC article.
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.
Takahashi T, Yamanaka T, Seto T, Harada H, Nokihara H, Saka H, Nishio M, Kaneda H, Takayama K, Ishimoto O, Takeda K, Yoshioka H, Tachihara M, Sakai H, Goto K, Yamamoto N. Takahashi T, et al. Among authors: takayama k. Lancet Oncol. 2017 May;18(5):663-671. doi: 10.1016/S1470-2045(17)30230-9. Epub 2017 Mar 23. Lancet Oncol. 2017. PMID: 28343976 Clinical Trial.
1,945 results